1Y Close · As of Aug 26, 2026
MEDIPOST operates in the Pharmaceuticals sector.
Legal name: MEDIPOSTCO.,LTD.
In fiscal year 2025, MEDIPOST (078160) reported revenue of 73.7 billion KRW, up 4.2% from 70.7 billion KRW a year earlier.
Operating profit was -68.0 billion KRW and net income was -86.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 347.4 billion KRW, with a P/B of 1.39.
These figures can be verified in the DART filing (receipt no. 20260319001247).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 73.7B | -68.0B | -86.0B |
| 2024 | 70.7B | -48.5B | -63.4B |
| 2023 | 68.6B | -25.1B | 5.0B |
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |